Intraoperative ICG plasma disappearance rate helps to predict absence of early postoperative complications after orthotopic liver transplantation

Journal of Clinical Monitoring and Computing

Volumn 27, Issue 5, 2013, Pages 591-598

  Vos, J J ^a   Scheeren, T W L ^a   Lukes, D J ^a,b   De Boer, M T ^a   Hendriks, H G D ^a   Wietasch, J K G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Early graft dysfunction; ICG; Indicator dilution technique; OLT; Point of care method

Indexed keywords

DILUTION TECHNIQUE; EARLY GRAFT DYSFUNCTION; ICG; OLT; POINT OF CARE;

FORECASTING; SURGERY;

INTENSIVE CARE UNITS;

BILIRUBIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INDOCYANINE GREEN; LACTIC ACID; PROTHROMBIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIARY TRACT DISEASE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CORRELATION ANALYSIS; DENSITOMETRY; FEMALE; GRAFT FAILURE; HEPATIC ARTERY THROMBOSIS; HUMAN; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LABORATORY TEST; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PH; POINT OF CARE TESTING; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; REOPERATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; BLOOD CHEMICAL ANALYSIS; EARLY DIAGNOSIS; GRAFT REJECTION; HUMANS; INDOCYANINE GREEN; LIVER TRANSPLANTATION; METABOLIC CLEARANCE RATE; MONITORING, INTRAOPERATIVE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84885020483     PISSN: 13871307     EISSN: 15732614     Source Type: Journal    
DOI: 10.1007/s10877-013-9474-1     Document Type: Article

References (42)

1. Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97:744-53.
2. Verdonk RC, van den Berg AP, Slooff MJ, Porte RJ, Haagsma EB. Liver transplantation: an update. Neth J Med. 2007;65:372-80.
3. Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transpl. 2003;17:401-11.
4. Chen H, Peng CH, Shen BY, et al. Multi-factor analysis of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int. 2007;6:141-6.
5. Chen GH, Fu BS, Cai CJ, et al. A single-center experience of retransplantation for liver transplant recipients with a failing graft. Transpl Proc. 2008;40:1485-7.
6. Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJ. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transpl. 1997;11:373-9.
7. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961;21:43-57.
8. Kuntz H, Schregel W. Indocyanine green: Evaluation of liver function; application in intensive care medicine. In: Lewis F, Pfeiffer U, editors. Practical applications of fiberoptics in critical care monitoring. New York: Springer; 1990. p. 57-62.
9. Levesque E, Saliba F, Benhamida S, et al. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl. 2009;15:1358-64.
10. Lock JF, Schwabauer E, Martus P, et al. Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl. 2010;16:172-80.
11. Jalan R, Plevris JN, Jalan AR, Finlayson ND, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation. 1994;58:196-200.
12. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg. 2009;108:1083-91.
13. Baulig W, Bernhard EO, Bettex D, Schmidlin D, Schmid ER. Cardiac output measurement by pulse dye densitometry in cardiac surgery. Anaesthesia. 2005;60:968-73.
14. Sekimoto M, Fukui M, Fujita K. Plasma volume estimation using indocyanine green with biexponential regression analysis of the decay curves. Anaesthesia. 1997;52:1166-72.
15. Pereboom IT, Adelmeijer J, van Leeuwen Y, Hendriks HG, Porte RJ, Lisman T. No evidence for systemic platelet activation during or after orthotopic liver transplantation. Liver Transpl. 2009;15:956-62.
16. Bruegger L, Studer P, Schmid SW, et al. Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. J Gastrointest Surg. 2008;12:67-72.
17. von Spiegel T, Scholz M, Wietasch G, et al. Perioperative monitoring of indocyanine green clearance and plasma disappearance rate in patients undergoing liver transplantation. Anaesthesist. 2002;51:359-66.
18. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl. 2006;6:783-90.
19. von Spiegel T, Giannaris S, Schorn B, Scholz M, Wietasch GJ, Hoeft A. Effects of induction of anaesthesia with sufentanil and positive-pressure ventilation on the intra- to extrathoracic volume distribution. Eur J Anaesthesiol. 2002;19:428-35.
20. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National institute of diabetes and digestive and kidney diseases liver transplantation database. Transplantation. 1998;66:302-10.
21. Lama C, Ramos E, Figueras J, et al. Predictive factors for postoperatory, early and late mortality in liver transplants. Transpl Proc. 2002;34:283-6.
22. Gonzalez FX, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology. 1994;20:565-73.
23. Rueggeberg A, Boehm S, Napieralski F, et al. Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia. 2008;63:1174-80.
24. Olmedilla L, Perez-Pena JM, Ripoll C, et al. Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl. 2009;15:1247-53.
25. Janssen MW, Druckrey-Fiskaaen KT, Omidi L, et al. Indocyanine green R15 ratio depends directly on liver perfusion flow rate. J Hepatobiliary Pancreat Surg. 2010;17:180-5.
26. Buis CI, Verdonk RC, Van der Jagt EJ, et al. Nonanastomotic biliary strictures after liver transplantation, part 1: radiological features and risk factors for early versus late presentation. Liver Transpl. 2007;13:708-18.
27. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992;53:957-78.
28. Kawasaki S, Sugiyama Y, Iga T, et al. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients. Am J Gastroenterol. 1985;80:801-6.
29. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16-22.
30. Stockmann M, Lock JF, Malinowski M, Neuhaus P. Evaluation of early liver graft performance by the indocyanine green plasma disappearance rate. Liver Transpl. 2010;16:793-4. author reply 795-6.
31. Hori T, Iida T, Yagi S, et al. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl. 2006;12:605-13.
32. Schneider L, Spiegel M, Latanowicz S, et al. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:362-8.
33. Rowell LB, Blackmon JR, Bruce RA. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest. 1964;43:1677-90.
34. de Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol. 2009;35:957-62.
35. Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med. 2000;26:1553-6.
36. Hoeft A, Schorn B, Weyland A, et al. Bedside assessment of intravascular volume status in patients undergoing coronary bypass surgery. Anesthesiology. 1994;81:76-86.
37. Sakka SG, van Hout N. Relation between indocyanine green (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med. 2006;32:766-9.
38. Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J Surg. 2006;76:75-7.
39. Imai T, Takahashi K, Goto F, Morishita Y. Measurement of blood concentration of indocyanine green by pulse dye densitometry-comparison with the conventional spectrophotometric method. J Clin Monit Comput. 1998;14:477-84.
40. Seibel A, Muller A, Sakka SG. Indocyanine green plasma disappearance rate for monitoring hepatosplanchnic blood flow. Intensive Care Med. 2011;37:357-9.
41. Sakka SG. Indocyanine green plasma disappearance rate during relief of increased abdominal pressure. Intensive Care Med. 2006;32:2090-1.
42. Vos JJ, Scheeren TW, Wietasch GJ. Pulse dye densitometry and indocyanine green plasma disappearance: The issue of "normal" values. Anesth Analg. 2010;111:1075-6. author reply 1076-7.